secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0000950170-25-008608
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Q4 revenue $18.3B, EPS $5.63; 2025 EPS guidance $24.05-$25.85; $10B buyback authorized
--------------------------------------------------------------------------------

- Q4 revenue $18.285B (+5.7% YoY); net income $1.438B ($5.63 diluted EPS) vs $1.607B ($5.93) in 4Q23; includes $0.60/sh hurricane impact.
- Adjusted EBITDA Q4 $3.712B vs $3.618B; same-facility admissions +3.0%, equivalent admissions +3.1%.
- Full year 2024 revenue $70.6B, net income $5.76B ($22.00 EPS) vs $5.24B ($18.97) in 2023; Adjusted EBITDA $13.88B.
- 2025 guidance: revenue $72.8-$75.8B, net income $5.85-$6.29B, EPS $24.05-$25.85, capex $5.0-$5.2B.
- Board authorized $10B share repurchase; quarterly dividend $0.72/share payable Mar 31 to record Mar 17.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000095017025008608/0000950170-25-008608-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000095017025008608/hca-20250124.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-008608

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer